近五年主持课题：
1、国家自然科学基金面上项目“LncRNA HCP5编码蛋白调控14-3-3ζ促进三阴乳腺癌恶性进展的机制研究”（81972478），55万；
2、东南大学人才启动金“LncRNA HCP5 作为ceRNA竞争结合miR-219a-5p调控BIRC3促进三阴乳腺癌恶性进展的机制研究”，30万；
3、国家自然科学基金青年项目“miR-155/PU.1/TAL-1通路调控乳腺癌细胞生物学功能的机制研究”（81202074），23万；
4、黑龙江省自然科学基金“miR-155靶向PU.1在乳腺癌细胞中的作用机制研究”（QC2016118），5万；
5、哈尔滨市科技创新人才优秀学科带头人专项资金“LncRNA HCP5作为ceRNA竞争结合miR-155调控转录因子PU.1促进乳腺癌恶性进展的机制研究”（2016RAXYJ107），5万；
6、东南大学基础科研扶持项目（2242018K40024），负责人。
近五年发表论文：
1、Lihong Wang*, Tian Luan, Shunheng Zhou, Jing Lin, Yue Yang, Wei Liu, Xiao Tong, Wei Jiang*. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p. Cancer medicine. 2019 May26; 8(9):4389-4403.
2、Leiming Jiang, Xuexin Yu, Xueyan Ma, Haizhou Liu, Shunheng Zhou, Xu Zhou, Qianqian Meng, Lihong Wang*, Wei Jiang*. Identification of transcriptionfactor-miRNA-lncRNA feed-forward loops in breast cancer subtypes.Computational Biology and Chemistry 2018.11.008.
3、Shunheng Zhou†, Lihong Wang†,Qian Yang, Haizhou Liu, Qianqian Meng, Leiming Jiang, Shuyuan Wang, Wei Jiang*. Systematicalanalysis of lncRNA-mRNA competing endogenous RNA network in breast cancersubtypes. Breast Cancer Research and Treatment 2018 Jun;169(2):267-275.
4、TianLuan, Ximei Zhang, Shuyuan Wang, Jing Lin, Weiwei An, Weiguang Yuan, HuilongCai, Qingyuan Zhang*, Lihong Wang*. Long non-coding RNA MIAT promotes breast cancerprogression and functions as ceRNA to regulate DUSP7 expression by spongingmiR-155. Oncotarget. 2017 Jul 12;8(44):76153-76164.
5、Jing Lin, Wei Liu, Tian Luan,Lili Yuan, Wei Jiang, Huilong Cai, Weiguang Yuan, Yuwen Wang, Qingyuan Zhang*, Lihong Wang*. High expression of PU.1 is correlation with Her-2 and shortersurvival in breast cancer patients. Oncology Letters. 2017 14: 8220-8226.
6、Weisha Liu, Shuyuan Wang,Shunheng Zhou, Feng Yang, Wei Jiang, Qingyuan Zhang*, LihongWang*. A systems biologyapproach to identify microRNAs contributing to cisplatin resistance in humanovarian cancer cells. Mol Biosyst. 2017 Oct24;13(11):2268-2276.
7、EnyuDai, Feng Yang,Jing Wang,Xu Zhou, Qian Song, Weiwei An, Lihong Wang*, Wei Jiang*. ncDR: a comprehensive resource of non-coding RNAs involved in drug resistance. Bioinformatics. 2017 Dec15;33(24):4010-4011.
8、Liu Xinyi, Feng Dongfei, Liu Dianming, Wang Shuyuan, Yu Xuexin, DaiEenyu, Wang Jing, Wang Lihong*,Jiang Wei*. Dissecting the Origin of Breast Cancer Subtype Stem Cell and thePotential Mechanism of Malignant Transformation. PLoS One. 2016 Oct21;11(10):e0165001.
9、Ximei Zhang†, Lihong Wang†, Dongju Su, Dan Zhu, Qiuming Li, Meihua Chi. MicroRNA-29b promotesthe adipogenic differentitation of human adipose tisse-derived stromal cells.Obesity 2016; 24(5):1097-105.
10、Yan Zhang, DianmingLiu, Lihong Wang, Shuyuan Wang, Xuexin Yu, Enyu Dai, Xinyi Liu, Sanshun Luo*, Wei Jiang*. Integrated systems approachidentifies risk regulatory pathways and key regulators in coronary arterydisease.